Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta cell cytoprotection using lentiviral vector-based iNOS-specific shRNA delivery.

Cillian McCabe1, Timothy O'Brien

  • 1REMEDI, NCBES, NUIG, Galway, Ireland.

Biochemical and Biophysical Research Communications
|April 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of endothelial colony forming cells in the treatment of limb ischaemia: challenges in clinical translation.

Stem cells translational medicine·2026
Same author

Compassion-focused group therapy improves depression, emotional eating, self-criticism and shame in people living with severe obesity: A single-centre, examiner-blind randomized controlled trial.

PloS one·2026
Same author

When Antibiotics Leave a Mark: Minocycline-Induced Hyperpigmentation.

Clinical case reports·2026
Same author

Survival Outcomes of BCG Only, BCG Plus EMDA-MMC or Upfront Radical Cystectomy in High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): A Multicentre, International, Collaborative Study from Tertiary Referral Institutions.

Cancers·2026
Same author

ATRA treatment in the emergency department is associated with reduced early mortality in acute promyelocytic leukemia-a real-world multicenter retrospective cohort analysis.

Leukemia & lymphoma·2026
Same author

Intravenous delivery of mesenchymal stromal cells reverses Müller cell endoplasmic reticulum stress in diabetic retinopathy.

Stem cell research & therapy·2025

Lentiviral shRNA vectors effectively silenced inducible nitric oxide synthase (iNOS) expression, protecting beta cells from cytokine damage. This novel approach offers a promising strategy against cytokine-induced beta cell toxicity.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Immunology

Background:

  • Cytokine exposure induces iNOS expression, leading to beta cell dysfunction and destruction.
  • Inhibiting iNOS expression is a potential therapeutic strategy for protecting beta cells.
  • Vector-based RNA interference offers a method for sustained gene silencing.

Purpose of the Study:

  • To evaluate the efficacy of lentiviral shRNA vectors in suppressing iNOS expression in a beta cell toxicity model.
  • To assess the protective effects of iNOS inhibition against cytokine-induced beta cell damage.
  • To determine if lentiviral vectors cause non-specific knockdown of other nitric oxide synthase isoforms.

Main Methods:

  • Utilized lentiviral shRNA vectors to target iNOS expression in insulinoma cells.

Related Experiment Videos

  • Exposed cells to IL-1beta to induce a cytokine-mediated toxicity model.
  • Measured insulinoma cell viability, iNOS expression, and nitrite accumulation.
  • Assessed for off-target effects on endogenous neuronal nitric oxide synthase (nNOS).

    • Main Results:

    • Lentiviral shRNA efficiently suppressed IL-1beta-induced iNOS expression.
    • Nitrite accumulation was significantly reduced following iNOS knockdown.
    • Lentiviral vector delivery provided significant protection against IL-1beta-induced cytotoxicity.
    • No non-specific knockdown of endogenous beta cell nNOS was observed.

    Conclusions:

    • Lentiviral vector-based shRNA is an effective tool for silencing iNOS expression in beta cells.
    • This strategy offers significant protection against cytokine-mediated beta cell toxicity.
    • The approach demonstrates specificity, avoiding detrimental effects on other NOS isoforms.